◂ Announcements

Sep 27, 2017ACQUISITIONUnited States

Sofie Biosciences completes acquisition of Zevacor Pharma

Sofie Biosciences completed the acquisition of Zevacor Pharma, forming a combined company called SOFIE. Zevacor Pharma operates 16 radiopharmacies and a contract manufacturing organization, serving over 425,000 patients annually.

Status

Completed

ProductsPET imaging compoundsradiopharmaceuticalsNeuraceqNETSPOT11C-CholineNaF

CompaniesSofie Biosciences acquirer Zevacor Pharma target

Sectors#Medical Devices

“As SOFIE, we'll continue Zevacor Pharma's commitment to customers, while making significant improvements to prepare us for growth.”sofie.com

1 source
sofie.comAcquisition of Zevacor Pharma Complete - SOFIEjsctek_u4g7i5Sep 27, 2017

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 6, 2026ACQUISITIONMinnesota, United States
Confluent Medical Technologies acquires Northern Nitinol
Confluent Medical Technologies acquirer Northern Nitinol target globenewswire.com medicaldesignandoutsourcing.com
Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com endata.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com

Loading…